LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 8337

Search options

  1. Book: Xian dai ming Zhong yi nan ke jue ji

    Chen, Wushan

    2002  

    Title translation Best practices of famous Modern Chinese traditional doctors in male diseases.
    Title variant Nan ke jue ji
    Author's details Chen Wushan bian zhu
    MeSH term(s) Genital Diseases, Male/drug therapy ; Medicine, Chinese Traditional
    Language Chinese
    Size 2, 10, 467 p. ;, 20 cm.
    Edition Di 1 ban.
    Publisher Ke xue ji shu wen xian chu ban she
    Publishing place Beijing Shi
    Document type Book
    ISBN 9787502338725 ; 7502338721
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  2. Book: Xian dai ming Zhong yi bu yun bu yu zhen zhi jue ji

    Chen, Wushan

    (Xian dai Zhong yi lin chuang cong shu)

    2002  

    Title translation Modern famous Chinese traditional doctors' best practice in diagnosis and treatment of infertility.
    Title variant Zhong yi bu yun bu yu zhen zhi jue ji
    Author's details zhu bian Chen Wushan, Liu Ying ; bian wei Qiu Jianhua, Qi Guoyuan
    Series title Xian dai Zhong yi lin chuang cong shu
    MeSH term(s) Infertility, Female/drug therapy ; Infertility, Male/drug therapy ; Medicine, Chinese Traditional.
    Language Chinese
    Size 6, 355 p. ;, 21 cm.
    Edition Di 1 ban.
    Publisher Ke xue ji shu wen xian chu ban she
    Publishing place Beijing
    Document type Book
    ISBN 9787502341503 ; 7502341501
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  3. Article ; Online: Novel statistics predict the COVID-19 pandemic could terminate in 2022.

    Chen, Ji-Ming

    Journal of medical virology

    2022  Volume 94, Issue 6, Page(s) 2845–2848

    Abstract: Many people want to know when the COVID-19 pandemic will end and life will return to normal. This question is highly elusive and distinct predictions have been proposed. In this study, the global mortality and case fatality rate of COVID-19 were analyzed ...

    Abstract Many people want to know when the COVID-19 pandemic will end and life will return to normal. This question is highly elusive and distinct predictions have been proposed. In this study, the global mortality and case fatality rate of COVID-19 were analyzed using nonlinear regression. The analysis showed that the COVID-19 pandemic could terminate in 2022, but COVID-19 could be one or two times more deadly than seasonal influenza by 2023. The prediction considered the possibility of the emergence of new variants of SARS-CoV-2 and was supported by the features of the Omicron variant and other facts. As the herd immunity against COVID-19 established through natural infections and mass vaccination is distinct among countries, COVID-19 could be more or less deadly in some countries in the coming years than the prediction. Although the future of COVID-19 will have multiple possibilities, this statistics-based prediction could aid to make proper decisions and establish an example on the prediction of infectious diseases.
    MeSH term(s) COVID-19/epidemiology ; Humans ; Immunity, Herd ; Pandemics ; SARS-CoV-2
    Language English
    Publishing date 2022-02-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.27661
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Ming qing qi yue wen shu zhong de fu nü jing ji huo dong

    Chen, Yingxun

    (Tai ming wen ku ; 9 ; 台明文庫 ; 9)

    2001  

    Author's details Chen ying xun zhu
    Series title Tai ming wen ku ; 9
    台明文庫 ; 9
    Keywords Women/Legal status, laws, etc ; Women/Economic conditions ; Women/Social conditions ; China
    Language Chinese
    Size xv, 317, [6], 33, 27 p, ill, 21 cm
    Edition 1 ban
    Publisher Tai ming wen hua shi ye you xian gong si
    Publishing place Tai bei
    Document type Book
    Note Includes bibliographical references
    ISBN 9579851484 ; 9789579851480
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  5. Article ; Online: Should the world collaborate imminently to develop neglected live-attenuated vaccines for COVID-19?

    Chen, Ji-Ming

    Journal of medical virology

    2021  Volume 94, Issue 1, Page(s) 82–87

    Abstract: The rapid spread of the Delta variant suggests that SARS-CoV-2 will likely be rampant for months or years and could claim millions of more lives. All the known vaccines cannot well defeat SARS-CoV-2 due to their limited efficacy and production efficiency, ...

    Abstract The rapid spread of the Delta variant suggests that SARS-CoV-2 will likely be rampant for months or years and could claim millions of more lives. All the known vaccines cannot well defeat SARS-CoV-2 due to their limited efficacy and production efficiency, except for the neglected live-attenuated vaccines (LAVs), which could have a much higher efficacy and much higher production efficiency than other vaccines. LAVs, like messiahs, have defeated far more pathogenic viruses than other vaccines in history, and most current human vaccines for viral diseases are safe LAVs. LAVs can block completely infection and transmission of relevant viruses and their variants. They can hence inhibit the emergence of vaccine-escape and virulence-enhancing variants and protect immunologically abnormal individuals better in general. The safety of COVID-19 LAVs, which could save millions of more lives, can be solidly guaranteed through animal experiments and clinical trials. The safety of COVID-19 LAVs could be greatly enhanced with intramuscular or oral administration, or administration along with humanized neutralizing monoclonal antibodies. Together, extensive global collaboration, which can greatly accelerate the development of safe COVID-19 LAVs, is imminently needed.
    MeSH term(s) COVID-19/prevention & control ; COVID-19 Vaccines/immunology ; Drug Development ; Humans ; Mass Vaccination ; SARS-CoV-2/immunology ; Vaccines, Attenuated/immunology
    Chemical Substances COVID-19 Vaccines ; Vaccines, Attenuated
    Language English
    Publishing date 2021-09-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.27335
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: China can prepare to end its zero-COVID policy.

    Chen, Ji-Ming / Chen, Yi-Qing

    Nature medicine

    2022  Volume 28, Issue 6, Page(s) 1104–1105

    MeSH term(s) COVID-19/epidemiology ; China/epidemiology ; Health Policy ; Humans
    Language English
    Publishing date 2022-04-06
    Publishing country United States
    Document type Letter
    ZDB-ID 1220066-9
    ISSN 1546-170X ; 1078-8956
    ISSN (online) 1546-170X
    ISSN 1078-8956
    DOI 10.1038/s41591-022-01794-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Editorial: Zoonotic emerging viral infectious diseases.

    Chen, Ji-Ming / Ji, Yu-Fei / Duan, Zhao-Jun / Wei, Bin

    Frontiers in veterinary science

    2023  Volume 10, Page(s) 1194324

    Language English
    Publishing date 2023-04-11
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2834243-4
    ISSN 2297-1769
    ISSN 2297-1769
    DOI 10.3389/fvets.2023.1194324
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: SARS-CoV-2 replicating in nonprimate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.

    Chen, Ji-Ming

    Journal of medical virology

    2020  Volume 93, Issue 1, Page(s) 351–356

    Abstract: Glycoproteins of enveloped viruses replicating in nonprimate mammalian cells carry α-1,3-galactose (α-Gal) glycans, and can bind to anti-Gal antibodies which are abundant in humans. The antibodies have protected humans and their ancestors for millions of ...

    Abstract Glycoproteins of enveloped viruses replicating in nonprimate mammalian cells carry α-1,3-galactose (α-Gal) glycans, and can bind to anti-Gal antibodies which are abundant in humans. The antibodies have protected humans and their ancestors for millions of years, because they inhibit replication of many kinds of microbes carrying αGal glycans and aid complements and macrophages to destroy them. Therefore, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replicating in nonprimate mammalian cells (eg, PK-15 cells) carry αGal glycans and could be employed as a live vaccine for corona virus 2019 (COVID-19). The live vaccine safety could be further enhanced through intramuscular inoculation to bypass the fragile lungs, like the live unattenuated adenovirus vaccine safely used in US recruits for decades. Moreover, the immune complexes of SARS-CoV-2 and anti-Gal antibodies could enhance the efficacy of COVID-19 vaccines, live or inactivated, carrying α-Gal glycans. Experiments are imperatively desired to examine these novel vaccine strategies which probably have the critical advantages for defeating the pandemic of COVID-19 and preventing other viral infectious diseases.
    MeSH term(s) Animals ; Antibodies, Viral/immunology ; COVID-19/prevention & control ; COVID-19 Vaccines/immunology ; Cell Line ; Humans ; SARS-CoV-2/physiology ; Viral Envelope Proteins/immunology
    Chemical Substances Antibodies, Viral ; COVID-19 Vaccines ; Viral Envelope Proteins
    Keywords covid19
    Language English
    Publishing date 2020-08-02
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.26312
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Live unattenuated vaccines for controlling viral diseases, including COVID-19.

    Chen, Ji-Ming

    Journal of medical virology

    2020  Volume 93, Issue 4, Page(s) 1943–1949

    Abstract: Live unattenuated vaccines (LUVs) have been neglected for decades, due to widespread prejudice against their safety, even though they have successfully controlled yellow fever and adenovirus infection in humans as well as rinderpest and infectious bursal ...

    Abstract Live unattenuated vaccines (LUVs) have been neglected for decades, due to widespread prejudice against their safety, even though they have successfully controlled yellow fever and adenovirus infection in humans as well as rinderpest and infectious bursal disease in animals. This review elucidated that LUVs could be highly safe with selective use of neutralizing antivirus antibodies, natural antiglycan antibodies, nonantibody antivirals, and ectopic inoculation. Also, LUVs could be of high efficacy, high development speed, and high production efficiency, with the development of humanized monoclonal antibodies and other modern technologies. They could circumvent antibody-dependent enhancement and maternal-derived antibody interference. With these important advantages, LUVs could be more powerful than other vaccines for controlling some viral diseases, and they warrant urgent investigation with animal experiments and clinical trials for defeating the COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2.
    MeSH term(s) Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/therapeutic use ; Antibodies, Viral/immunology ; Antibodies, Viral/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/prevention & control ; COVID-19 Vaccines ; Humans ; Injections, Intramuscular ; Vaccination/methods ; Vaccines, Live, Unattenuated/therapeutic use ; Viral Vaccines/therapeutic use ; Virus Diseases/prevention & control
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Antiviral Agents ; COVID-19 Vaccines ; Vaccines, Live, Unattenuated ; Viral Vaccines
    Keywords covid19
    Language English
    Publishing date 2020-09-29
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.26453
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Dual impacts of the COVID-19 nonpharmaceutical interventions on other infectious diseases.

    Chen, Yi-Qing / Ji, Yu-Fei / Chen, Ji-Ming

    Journal of medical virology

    2022  Volume 94, Issue 10, Page(s) 4588–4590

    MeSH term(s) COVID-19/prevention & control ; Communicable Diseases ; Disease Outbreaks ; Humans ; SARS-CoV-2
    Language English
    Publishing date 2022-06-16
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.27922
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top